This document discusses hepatorenal syndrome (HRS), an acute kidney injury that can occur in patients with cirrhosis and liver failure. It provides updates on diagnostic criteria and classifications of HRS subtypes. The pathophysiology of HRS involves increased blood flow to the gut, decreased central blood volume, and kidney vasoconstriction. Risk factors include advanced cirrhosis and bacterial translocation. Terlipressin with albumin is the standard treatment and can reverse HRS, though noradrenaline is also effective with fewer side effects. The timing of renal replacement therapy and role of liver transplantation in HRS are also reviewed.